BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

May 13, 2009

View Archived Issues

SkinMedica and Allergan sign U.S. copromotion agreement for acne treatment Aczone

Read More

Roche partners with Tekmira to advance its RNAi product candidates

Read More

Intercell signs supply contract with U.S. military for Japanese encephalitis vaccine Ixiaro

Read More

Discovery and FDA to meet in June 2009 regarding marketing approval of Surfaxin

Read More

Sanofi-aventis acquires U.S. commercial rights to Antisoma's B-cell CLL drug Oforta

Read More

Preclinical data point to activity against psoriasis with PDE7 inhibitor ASB-16165

Read More

PAR-2 antagonism with NP-003 possibly useful for atopic dermatitis, skin whitening

Read More

Leuprorelin may be beneficial in spinal and bulbar muscular atrophy

Read More

Two large studies show antimigraine efficacy of telcagepant

Read More

Diabetic peripheral neuropathic pain reduced from severe to mild with tapentadol ER

Read More

Aliskiren/amlodipine combination effective in hypertensives treated over one year

Read More

Janssen claims gamma-secretase modulators for the treatment of Alzheimer's disease

Read More

Janssen describes c-FMS kinase inhibitors for the treatment of inflammatory conditions

Read More

Phosphodiesterase 4B inhibitors discovered by Boehringer Ingelheim for respiratory disorders

Read More

Topical administration of 17beta-estradiol prodrug confers retinal protection in rat glaucoma model

Read More

S1P1 inhibitor XL-541 enhances the oncolytic activity of paclitaxel in preclinical studies

Read More

Monoclonal antisera against fibroblast growth factor-2 or its receptor show antineoplastic activity

Read More

Dara BioSciences reports favorable results for KRN-5500 in neuropathic pain

Read More

FDA accepts Arno's IND for the use of AR-12 in adults with solid tumors or lymphoma

Read More

AstraZeneca completes approval procedure for Nexium in preventing peptic ulcer re-bleeding

Read More

Pfizer's Lyrica now available for fibromyalgia in Canada

Read More

NovImmune reacquires rights to NI-0401 and NI-0501 from Merck Serono

Read More

New-generation therapeutic for cognitive impairment enters clinical trials at Synosia

Read More

Phase I/II study of lisofylline in type 1 diabetes set to begin

Read More

FDA accepts as complete AMAG's resubmission of NDA for Feraheme

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 11, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing